1. United States of America Stocks

  2. •

    Financial Services

  3. •

    Shell Companies
Ibere Pharmaceuticals

Ibere Pharmaceuticals

IBER-UN
Ibere PharmaceuticalsUS flagNew York Stock Exchange
10.16
USD
- -
- -
Ibere Pharmaceuticals
IBER-UN
(New York Stock Exchange)

Recent

price

10.16

P/E

ratio

- -

div

yld

- -

ROIC.AI

No data availableFinancial data will appear here once available

Capital Structure

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Working Capital

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Growth Rates

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Quarterly Revenue

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available
Similar Companies
TCW Special Purpose Acquisition Corp. (TSPQ-UN)
Black Mountain Acquisition Corp. (BMAC)
Auscan Resources Inc. (AHELF)
Vahanna Tech Edge Acquisition I Corp. (VHNA)
Bold Eagle Acquisition Corp. (BEAG)
Launch One Acquisition Corp. (LPAAW)
Business
Ibere Pharmaceuticals Ibere Pharmaceuticals (IBER-UN) is a blank check company with no significant current operations. It focuses on effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization, or other similar business combination with one or more businesses or entities, particularly targeting opportunities in the pharmaceutical sector. Incorporated in 2020 as a Cayman Islands exempted company and headquartered in Philadelphia, Pennsylvania, the company completed its initial public offering of $138,000,000 in 2021 to fund its pursuit of a business combination.